The Pharmaceutical Market: Pakistan

Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting the pharmaceutical market in context. The reports provide:

Five-year projections for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators.

Specialised intelligence on OTCs, generics, biologics and biosimilars.

Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the series.

A separate statistical health file, comprising health expenditure, health infrastructure, health services and health personnel.

The reports are updated quarterly, providing you with the latest information for a full year. In addition, the service will keep you up to date with market and industry news on a regular basis.

• Executive Summary
• Introduction
  • Pharmaceutical Market Analysis
  • Size
  • Market Structure
  • Generics Sector
  • Projections & Outlook
  • Imports
  • Domestic Manufacturing
  • Domestic Production
  • Local Manufacturers
  • CCL
  • Cyanamid (Pakistan), Wyeth Lederle Division
  • Efroze
  • Epla Labs
  • Highnoon Laboratories
  • Kobec Pharmacals
  • Dr Raza Pharma
  • ZAFA Pharmaceutical Laboratories (Private)
• Multinational Manufacturers
  • Abbott Laboratories (Pakistan)
  • GlaxoSmithKline Pakistan
  • Reckitt Benckiser Pakistan
  • sanofi-aventis
  • Searle Pakistan
  • Biotechnology
  • Biological Production Division (BPD) to Restart Production of Vaccines
  • Pakistan's First Biotech Manufacturing Plant
  • Exports
  • Balance of Trade
  • Research & Development
  • Pharmaceutical Regulatory Analysis
  • Pharmaceutical Regulation
  • Pharmaceutical Registration
  • Registration Fees
  • Licensing
  • Retail Licences
• PAKISTAN
  • Manufacturing Licences
  • Labelling & Packaging
  • Labelling & Packaging Dispute
  • Post-Marketing Surveillance
  • Advertising
  • Pricing & Reimbursement
  • Pricing Development
  • Sales Tax Confusion
  • Medicine Tariffs Abolished
  • Prices of 240 Drugs Increased by up to 20%
  • Intellectual Property
  • Patent Protection & Intellectual Property Rights
  • Background to Current Situation
  • 2,000 MNC Patent Applications Withdrawn or Rejected Following Pressure from PPMA
  • Counterfeit Pharmaceuticals
  • Counterfeit Drugs Account for 40-50% of Drugs Available in Pakistan
  • Drive Against Spurious Drugs Launched
  • Drug Smuggling Estimated at Rs1 5 Billion
  • Over 50% of Drugs in the Sindh Region are Reported to be Counterfeit
  • Pharmaceutical Distribution
  • Wholesaling/Importers
  • Healthcare Analysis
  • Demographics
  • Population
  • Birth Rate
  • Death Rate
  • Infant Mortality
  • Life Expectancy at Birth
  • Public Health
  • Causes of Death
  • Incidence of Communicable Diseases & Non-communicable diseases
  • HIV/AIDS
  • Healthcare System
  • Organisation & Administration
  • Health Expenditure
  • Healthcare Infrastructure
  • Healthcare Personnel
• DIRECTORY
  • Government Organisations
• PAKISTAN
  • Trade Associations
  • Methodology & Sources
• List of Tables
  • Summary of Key Data Projections, 2010-2015
  • Summary of the Pakistan Pharmaceutical Market, 2010
  • Market Projections, 2010-2015
  • SWOT Analysis of the Pakistan Pharmaceutical Market, 2010
  • Pharmaceutical Imports by Category, 2004-2008 (US$000s)
  • Imports of Raw Materials by Country/Region, 2008 (US$000s)
  • Imports of Antisera & Vaccines by Country/Region, 2008 (US$000s)
  • Imports of Medicaments by Country/Region, 2008 (US$000s)
  • Pharmaceutical Manufacturing Plants by Province
• Multinational Manufacturers
  • Pharmaceutical Exports by Category, 2004-2008 (US$000s)
  • Pharmaceutical Exports by Country/Region, 2008 (US$000s)
  • Pharmaceutical Balance of Trade, 2004-2008 (US$000s)
  • Registered Drugs under the 1976 Drugs Act
  • Registered Drugs, 1999-2004
  • Registration Fees (Rs)
  • Drug Manufacturing License (Rs)
  • Summary of Demographic Data, 2005 & 2008
  • Projected Population, 2010-2015
  • Healthcare Expenditure, 2005-2006
  • Projected Health Expenditure, 2010-2015
  • Hospitals & Beds, 2008
  • Projected Number of Physicians, 2010-2015
• PAKISTAN
• List of Charts
  • Radar Graph of the Pakistan Pharmaceutical Market, 2010
  • Pharmaceutical Imports, 2003-2008 (US$ Millions)
  • Pharmaceutical Imports by Country/Region, 2008 (%)
  • Pharmaceutical Exports, 2003-2008 (US$ Millions)
  • Pharmaceutical Balance of Trade, 2003-2008 (US$ Millions)